サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Partnerships, Licensing, Investments and M&A Deals and Trends for March 2019 in Pharmaceuticals

製薬産業における提携・ライセンス・投資・M&A、および動向(2019年3月)

レポート概要

本レポートは、製薬産業における提携・ライセンス・投資・M&A、および資金調達に関するデータおよび動向を分析します。また、2019年3月に製薬産業で起こった、提携、ライセンス業務、M&A、株式/債券の発行、未公開株式、およびベンチャー資金調達に関する詳細情報を提供します。さらに、取引タイプ別・治療分野別・地域別に、過去6か月間の取引件数およびそれらの価値に関する詳細な比較のデータ、および製薬産業におけるトップの金融顧問会社に関する情報を提供します。

本レポートのデータは、GlobalData社の社内データベース、一次調査、および二次調査に基づいています。

■ 調査範囲

  • 世界の製薬産業のための市場動向の分析
  • 心血管、中枢神経系、皮膚科、耳鼻咽喉科疾患、胃腸、泌尿生殖器系および性ホルモン、血液疾患、ホルモン障害、免疫系、感染症、男性の健康、代謝性障害、口腔および歯科疾患、筋骨格、腫瘍(癌)、眼科、呼吸器、毒物学、女性の健康のセグメントにおける取引のレビュー
  • 製薬産業における、提携、ライセンス、M&A、株式/債券の発行、未公開株式、およびベンチャー資金調達取引に関する分析
  • ベンチャー資金調達、提携、ライセンス契約、株式/債券の発行、およびM&Aに関して非常に活発な治療分野の分析
  • 主に、製薬産業での提携およびライセンス契約における、前払い/マイルストーン払いを含むさまざまな支払方法に基づいた取引の分析
  • 製品の開発の臨床段階に基づいた提携およびライセンス取引の分析
  • 過去6か月の世界の製薬取引の概要
  • 製薬産業で起こったトップ取引に関する情報
  • 北アメリカ、ヨーロッパ、アジア太平洋地域(APAC)、南および中央アメリカ、中東およびアフリカ(MEA)の地域分析
  • M&Aおよび株式/債券の発行における財務顧問(Morgan Stanley社、Credit Suisse社、およびGoldman Sachs社を含む)のリーグ・テーブル

レポート詳細

目次

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2019
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, March 2019
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, March 2019
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March 2019

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, March 2019
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, March 2019
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, March 2019
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2019
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, October 2018 - March 2019
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), March 2019
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, October 2018 - March 2019
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), October 2018 - March 2019
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), October 2018 - March 2019

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2019
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2019
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2019
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), October 2018 - March 2019
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), October 2018 - March 2019
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), October 2018 - March 2019
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), October 2018 - March 2019

5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, March 2019
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, March 2019
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, March 2019
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, March 2019
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, March 2019
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, March 2019
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, March 2019

6 Deal Summary by Geography
6.1 Pharmaceuticals & Healthcare, North America Deals, March 2019
6.2 Pharmaceuticals & Healthcare, Europe, Deals, March 2019
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, March 2019
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, March 2019

7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, October 2018 - March 2019
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, October 2018 - March 2019

8 Further Information
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclosure information
8.5 Disclaimer

List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, March 2019
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), March 2019
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, March 2019
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, October 2018 - March 2019
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, March 2019
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, March 2019
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, October 2018 - March 2019
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), March 2019
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, October 2018 - March 2019
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), March 2019
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, October 2018 - March 2019
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), October 2018 - March 2019
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), March 2019
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, October 2018 - March 2019
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2019
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, March 2019
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, March 2019
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, March 2019
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), October 2018 - Ma

List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), March 2019
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), March 2019
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, October 2018 - March 2019
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, October 2018 - March 2019
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), March 2019
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), March 2019
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, October 2018 - March 2019
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, October 2018 - March 2019
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), October 2018 - March 2019
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, October 2018 - March 2019
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), October 2018 - March 2019
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), March 2019
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), October 2018 - March 2019
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), October 2018 - March 2019

発刊日

2019/04/30

体裁

PDF / 86ページ

販売価格

1,000USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

企業 / メディカル・バイオ(その他) / 経営マネジメント

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE